Felypressin

This classification denotes an antidiurectic hormone analogue with the molecular formula C46H65N13O11S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 17N2918V6G, chemically known as vasopressin, 2-l-phenylalanine-8-l-lysine- but generally known as felypressin, which bears US NIH Compound Identifier 5956. European Medicines Agency schedules Felypressin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07529MIG. The term FELYPRESSIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). FELYPRESSIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule felypressin under HS 29371900 and SITC 54154. As of Q4 2014, FELYPRESSIN remains the US FDA Preferred Term for this commodity. Felypressin bears US NLM identifiers UMLS ID C0015777 and NCI Concept Code C81496. SMILES: S1SCC(N)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2C(CCC2)C(=O)NC(CCCCN)C(=O)NCC(=O)N)C1)CC(=O)N)CCC(=O)N)CC1CCCCC1)CC1CCCCC1.